By Eashwar K P and Dr Amrutha Ashok
Once viewed as an esoteric Eastern tradition, Ayurveda is now steadily gaining ground across Europe—as a holistic, evidence-informed complement to modern medicine. From Germany’s integrative clinics to Switzerland’s insurance-backed therapies, the ancient Indian system is being embraced for its emphasis on preventive care, mental well-being, and chronic disease management. Yet, regulatory hurdles, limited clinical validation, and fragmented policy landscapes remain. As India strengthens its trade and diplomatic efforts, and the WHO champions traditional medicine, Ayurveda’s role in shaping Europe’s future healthcare narrative is becoming increasingly significant. This cover story explores the evolving landscape, challenges, and immense potential of Ayurveda in Europe.
Introduction: A Tradition Reawakens in the West
Once relegated to the margins of alternative health discussions in Europe, Ayurveda—a 5000-year-old holistic system of healing from India—is experiencing a quiet renaissance. The rising global quest for sustainable health solutions, deeper mind–body integration, and natural therapeutics has led to a perceptible shift in the European mindset. Today, Ayurveda is not only gaining acceptance as a complementary system of healthcare but is also influencing policy dialogues, medical education, and cross-border trade across the continent.
This story traces Ayurveda’s journey in Europe—how perceptions are changing, how deep its roots have spread in various countries, what barriers it still faces, and how integrative models are opening up transformative possibilities in healthcare. It also unpacks India’s trade dynamics with Europe in Ayurvedic products and explores the growing role of WHO in legitimising traditional medicine worldwide.
Changing Perceptions: From Exotic to Essential
Not long ago, Ayurveda was perceived in Europe as an exotic, mystical Eastern practice—often lumped together with astrology or spiritual healing. The knowledge gap was vast, and scepticism was common among both health professionals and policymakers. However, this perception has significantly evolved in the past two decades.
The rise of wellness tourism to India and Sri Lanka, increased scientific inquiry into herbal pharmacology, and cross-cultural exposure through yoga and meditation have softened attitudes. Several European countries now regard Ayurveda as a viable complementary and alternative medicine (CAM) system.
In Germany, for instance, Ayurveda is recognized by the Central Association of Physicians for Naturopathy and Complementary Medicine (ZÄN). Prestigious universities such as Charité Medical University in Berlin conduct Ayurvedic research and offer modules in medical curricula. In Switzerland, Ayurveda has been integrated into public insurance coverage for certain therapies.
The pandemic further accelerated the shift. With the limitations of allopathy in treating long COVID, anxiety, and lifestyle-induced disorders, more patients and practitioners turned to traditional systems for resilience and recovery. Integrative Healthcare: Measurable Transformations
The incorporation of Ayurveda into mainstream healthcare in Europe is no longer anecdotal; it is now backed by peer-reviewed, clinical evidence showing measurable improvements in patient outcomes and cost-effectiveness—particularly in managing chronic and lifestyle-related disorders.
In Germany, a randomised controlled trial conducted by Prof. Andreas Michalsen and his team at the Charité Medical University, Berlin, involved 151 patients with osteoarthritis of the knee. The study, published in Evidence-Based Complementary and Alternative Medicine (2018), found that patients receiving Ayurvedic treatment showed significantly better
outcomes than those receiving conventional care. The WOMAC index scores improved by 61 points in the Ayurveda group compared to 32 points in the standard care group (p < 0.001, Cohen’s d = 0.68), with benefits sustained for up to a year (https://pmc.ncbi.nlm.nih.gov/articles/PMC6333787/).
In Austria, a pilot study published in the Journal of Integrative and Complementary Medicine (March 2024) assessed the effects of a 4-month online Ayurveda-based lifestyle and detox programme on 98 participants. Conducted by Susanne Schmiedel, MD, and collaborators from Immanuel Albertinen Diakonie and the European Academy of Ayurveda (Birstein, Germany), the study found statistically significant improvements in anxiety, depression, fatigue, physical symptoms, and BMI, with large effect sizes across multiple parameters (https://www.liebertpub.com/doi/full/10.1089/jicm.2024.0489).
A European multi-centre observational study led by Dr Hedwig H Gupta and colleagues from the Rosenberg European Academy of Ayurveda, and published in Complementary Therapies in Medicine (2023), evaluated outcomes for 170 clients receiving Ayurvedic consultations across several European countries. The findings were compelling:
· 85% of patients were satisfied with the outcomes,
· 61% reported ‘much to exceptional’ health benefits,
· 63% observed notable improvement in physical, emotional, digestive, or energy-related issues (https://pubmed.ncbi.nlm.nih.gov/36822960/).
From a cost-effectiveness standpoint, the WHO and several EU-based institutions recognize Ayurveda as part of the broader Traditional, Complementary, and Integrative Medicine (TCIM) framework. A review of integrative medicine economics by Dr Claudia Witt (University of Zurich, 2010) indicated that systems emphasizing prevention and holistic care—such as Ayurveda—could significantly reduce long-term healthcare costs, particularly in chronic pain, stress, and metabolic disorders (https://pubmed.ncbi.nlm.nih.gov/20832763/).
Though large-scale insurance-based trials are still evolving, Ayurveda is already being adopted in hospital-affiliated wellness centres, rehabilitation clinics, and corporate health
programmes across Europe. The growing demand for evidence-based, structured clinical protocols is further accelerating its integration into European healthcare ecosystems.
European Penetration: A Country-Wise Snapshot
Ayurveda’s reach across Europe is neither uniform nor accidental—it reflects cultural openness, regulatory landscapes, and health economics in each country. Given below is brief account of Ayurveda’s status in some of the prominent countries in Europe.
Germany Germany is arguably the most fertile ground for Ayurveda in Europe. The country has a long tradition of naturopathy and is open to CAM practices. The European Academy of Ayurveda in Birstein has been a cornerstone for education and clinical practice. Several spas and clinics integrate Panchakarma and Ayurvedic consultations with modern diagnostics.
Switzerland Switzerland has been at the forefront of validating traditional medicine. Ayurveda is included under the umbrella of therapies covered by basic health insurance (with certified practitioners), and the country supports formalized training through institutions such as the Ayurveda Academy in Lucerne.
United Kingdom Though more conservative in approach, the UK has a growing number of Ayurvedic centres. Ayurveda Pura in London and the College of Ayurveda (UK) are noteworthy. However, stringent regulations of MHRA (Medicines and Healthcare Products Regulatory Agency) have curtailed the availability of certain herbal formulations. Yet, integrative medicine is making inroads, particularly in private practice.
Italy and France Both countries show promising growth in Ayurveda, though often restricted to private wellness and retreat centres. Regulatory structures remain ambiguous. Ayurveda is more prominent in the beauty, wellness, and detox sectors than in clinical therapeutics.
Nordic Nations Sweden, Norway, and Denmark are seeing a growing interest in Ayurveda, particularly for stress management, nutrition, and seasonal health. However, there is still caution in integrating it into formal healthcare due to lack of regulatory clarity.
Regulatory Challenges: Between Tradition and Bureaucracy
Despite increasing interest, Ayurveda’s growth in Europe is tempered by several regulatory hurdles.
· Lack of Uniform Framework: The European Union does not have a common policy for traditional medicine systems. This creates a patchwork of rules that vary significantly from one member country to another.
· Herbal Medicine Regulation: The Traditional Herbal Medicinal Products Directive (THMPD) 2004/24/EC under EU law mandates rigorous testing and registration for herbal formulations. Many Ayurvedic products, particularly those with complex compound formulations, fail to meet the documentation requirements or lack the funds for extensive clinical trials.
· Professional Licensing: In most European countries, there is no standardized system for Ayurvedic practitioner licensing. This leaves room for both qualified professionals and unregulated charlatans, undermining public trust.
· Scientific Scepticism: While modern research on Ayurvedic botanicals such as Ashwagandha, Turmeric, and Triphala has grown, mainstream European medical circles still demand large-scale, peer-reviewed trials before accepting Ayurveda’s efficacy in clinical settings.
These challenges demand more robust diplomatic, academic, and trade engagements between India and Europe.
India–Europe Trade: Numbers and Opportunities
India’s exports of Ayurvedic products to Europe have seen a steady uptick, although they still form a fraction of the global market. According to the Ministry of Commerce (India), India’s total export of Ayurvedic and herbal products stood at approximately $800 million in
FY 2023/24. Europe accounted for nearly 20% of this, led by Germany, the UK, France, and the Netherlands.
· Germany alone imported over ₹400 crore worth of herbal and Ayurvedic products in 2023, including nutraceuticals, essential oils, and raw herbs.
· The UK is a significant consumer of Ayurvedic cosmetics and dietary supplements.
· France and the Netherlands are emerging markets for certified organic Ayurvedic teas, balms, and oils.
However, Ayurveda’s potential is yet to be fully realized. With increasing efforts towards more stringent quality standards, harmonized labelling norms, and streamlined supply chains, trade in Ayurveda products/services is expected to do much better in the coming years.
The Ministry of AYUSH has taken several proactive steps including:
· Promoting AYUSH clusters with EU-compliant Good Manufacturing Practices (GMP).
· Facilitating Mutual Recognition Agreements (MRAs).
· Launching the AYUSH Export Promotion Council (AYUSHEXIL).
With Europe’s increasing focus on plant-based and preventive health systems, India’s Ayurvedic exports are well poised to expand.
Integrative Medicine: Treating the Whole Person
Perhaps the most exciting frontier is the emergence of integrative medicine. This model combines conventional biomedicine with evidence-based traditional systems—offering a ‘whole person’ approach that is especially effective for chronic, lifestyle-related, and psychosomatic conditions. For instance, the areas where Ayurveda is complementing Western medicine in Europe are as listed below:
§ Chronic Pain and Arthritis: In Germany and Switzerland, Ayurvedic massage therapies, herbal poultices, and Rasayana regimens are being used alongside physiotherapy and anti-inflammatory drugs.
§ Mental Health: Ayurvedic lifestyle counselling, nasya, and adaptogenic herbs like Brahmi and Ashwagandha are used to treat anxiety, sleep disorders, and mild depression, often in integrative clinics.
§ Metabolic Disorders: Diabetes and obesity management now increasingly involve Ayurvedic dietary protocols, detox therapies, and yoga.
§ Oncology Support: Ayurvedic immunity-boosting and detoxifying protocols are offered as adjunctive care during cancer treatment in select European clinics.
Moreover, some pilot projects are exploring Ayurveda in managing long COVID, autoimmune diseases, and women’s health (like PCOS and endometriosis).
While full-scale integration into national health systems remains a long-term goal, early collaborations between Ayurveda practitioners and allopathic doctors are sowing the seeds of trust.
WHO’s Role in Traditional Medicine Integration
The WHO has played a pivotal role in repositioning traditional medicine, including Ayurveda, as a vital part of global health. Key milestones include:
· WHO Traditional Medicine Strategy 2025–2034: Adopted by WHA in its 78th session on 27 May 2025, aims to strengthen the role of traditional and complementary medicine in health systems.
· Global Traditional Medicine Centre (GTCM): Inaugurated in Jamnagar, India, in 2022, the GCTM serves as a hub for global collaboration on traditional medical systems, with a vision to integrate them scientifically and ethically.
WHO’s recent European Traditional Medicine Report (2023) recommended increased documentation, research, and regulation of CAM therapies across Europe, and recognized Ayurveda among the influential systems under this domain.
Prof. Pawankumar Ramesh Godatwar, Technical Officer for Traditional Medicine at the WHO South-East Asia Regional Office (SEARO), emphasises that
‘‘Ayurveda’s deeper integration into European health systems hinges on increased documentation, rigorous research, and robust regulation, ensuring its safe and evidence-based acceptance.’’
This underscores the international consensus that Ayurveda’s global future lies in scientific credibility and regulatory alignment, particularly in regions like Europe, where integrative healthcare is gaining traction.
The collaboration between WHO, India’s Ministry of AYUSH, and European public health bodies is expected to deepen in the coming years—helping create interoperable frameworks for training, product regulation, and clinical validation.
Looking Ahead: A Shared Future in Healing
Europe’s embrace of Ayurveda reflects more than just a health trend—it’s a deeper shift towards holistic, sustainable, and preventive healthcare. As climate change, mental health crises, and antibiotic resistance redefine global health priorities, Ayurveda offers wisdom honed over millennia.
Yet the road ahead demands commitment from all stakeholders.
· India must invest in standardization, clinical research, and transparent regulation.
· Europe must revisit outdated biases and create enabling environments for pluralistic healthcare.
· Academia must foster dialogue between disciplines, enabling Ayurveda to be studied, validated, and innovated upon.
· International bodies like WHO must continue to foster global guidelines that protect both safety and heritage.
For the millions seeking healing that addresses the root causes—not just the symptoms—Ayurveda in Europe is not a revival. It is a rebalancing.
Conclusion: Reclaiming the Balance
As Ayurveda gradually finds a home in European hearts, clinics, and conversations, the ancient principle of Swasthasya Swasthya Rakshanam (preserving the health of the healthy) resonates anew. Whether in a Berlin hospital ward, a Swiss wellness spa, or a London yoga studio, the pulse of Ayurveda is steady and strong.
Europe, once the epicentre of biomedicine’s rise, now becomes a bridge where tradition and modernity meet not in conflict, but in convergence.
